CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Grant or award SVP - CORP. DEV. & STRATEGY acquired 11,116 shares (grant or award)
- 4 Grant or award SVP, CHIEF HR OFFICER acquired 10,810 shares (grant or award)
- 4 Grant or award SR. VP, GENERAL COUNSEL & SEC. acquired 13,895 shares (grant or award)
- 4 Grant or award SVP & CFO acquired 22,233 shares (grant or award)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale HEAD OF RARE DISEASE sold 5,323 shares at $78.02 ($415,300)
- 4 Planned sale SVP, CHIEF HR OFFICER sold 3,814 shares at an average $77.74 ($296,495)
- 4 Shares withheld for taxes SVP, HEAD - ESTABLISHED BRANDS gave up 1,051 shares (to pay taxes)
- 4 Planned sale HEAD OF RARE DISEASE sold 7,032 shares at $76.55 ($538,300)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 21,986 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GENERICS gave up 3,663 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - CORP. DEV. & STRATEGY gave up 3,325 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHIEF HR OFFICER gave up 2,470 shares (to pay taxes)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $76.80 ($38,400)
- 4 Shares withheld for taxes SVP & CFO gave up 5,277 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & CFO gave up 5,503 shares (to pay taxes)
- 4 Shares withheld for taxes SR. VP, GENERAL COUNSEL & SEC. gave up 3,011 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CHIEF HR OFFICER gave up 3,017 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - CORP. DEV. & STRATEGY gave up 4,269 shares (to pay taxes)
Page 5 of 90 · 1,784 filings